Persons who have believe they may be eligible for the scholarly study should contact ARCA in or 404-876-2317. ARCA can be interested in identifying possible applicants who match the enrollment requirements but have not yet started anti-HIV drugs.. ARCA receives approval to begin enrollment of first therapeutic trial with GeoVax vaccine GeoVax Labs, Inc. , a biotechnology firm that creates, develops and tests innovative HIV/AIDS vaccines, announced today The Helps Research Consortium of Atlanta has received authorization to begin with enrollment of the 1st therapeutic trial ever carried out using a promising HIV vaccine applicant from GeoVax, Inc. Although the GeoVax vaccines are currently being studied for HIV avoidance, this is actually the first study using the same products for treatment of individuals who curently have HIV infection.Meanwhile, wellness. But doctors have said they can’t be sure what helped Sacra recover because he was getting multiple treatments. Meanwhile in Texas, Gov. Rick Perry stated he would create circumstances task force to ensure Texas responds to infectious illnesses just like the Ebola virus. THE DUTY Force on Infectious Disease Response and Preparedness will be overseen by Dr. Brett Giroir, the CEO of Texas A&M Wellness Science Center.